---
category: news
title: "Predictive Oncology’s Wholly Owned Subsidiary Helomics announces the start of its drug ..."
excerpt: "Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced today that it will start an in-house drug repurposing project,"
publishedDateTime: 2021-02-08T14:33:00Z
originalUrl: "https://apnews.com/press-release/globe-newswire/technology-business-medication-pharmaceutical-manufacturing-health-care-industry-571228f919c18b812ab409f6990ccf0f"
webUrl: "https://apnews.com/press-release/globe-newswire/technology-business-medication-pharmaceutical-manufacturing-health-care-industry-571228f919c18b812ab409f6990ccf0f"
type: article
quality: 12
heat: 12
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "nWNWZvj/yDFDfUWmAuM/59LAqxuuqzHAT/7oGYGNtAGn5w9BkM3tgMnPR8AdCz+651Vu9rS/cf8fcesW9i4VKjzzBStVnht3f84bxqvH150H0Y7F4vi64h+3dtGsA6tFLQ1vMz7acXqjIQQnxGgXaSCf4TxYR3z8yEIBWU/Wv2bw/ot6PwhdiV2il9dxD0KemHXrSP/BF5H3pAaSr8ckhE89VX8W5KwwSUM9hfudykbJd4qvsRtIOY042rZy41X49yco7bFuuVmPPc0H6Nw5kaDyNyr5h5GsAkcsr/b6Hgv6iAAgbkcAAL+q68xBJs636ZCyvgC3Kc7uo9vcwm996zeUyavRLCjnZ8uGhUldhak=;hOeF+lacYWt/iPGKVWmCNw=="
---

